Symposium - Annecy, France
Vaccine efficacy reflects the proportionate reduction in disease incidence between unvaccinated and vaccinated individuals. While vaccines are typically licensed on the basis of demonstrated efficacy, the ultimate goal of vaccination is to achieve a significant public health impact in addition to the prevention of infection in an individual. In this respect, there is a need to provide a broader perspective that encompasses the capacity of a vaccination program to reduce microbial transmission, avert disease, disability and premature deaths, and to lessen the pressure on health system and to reduce health inequities between populations. These issues are particularly relevant for some of the newer vaccines (e.g., rotavirus, dengue, and malaria vaccines) that demonstrate lower efficacy in high burden settings than traditional vaccines, but nevertheless could have a substantial overall public health impact in these settings.
- Organization: Fondation Mérieux
- Beyond Efficacy: The full public health impact of Vaccines
Mon, Jun 22, 2015 - Wed, Jun 24, 2015
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.